跳至主要内容
临床试验/NCT01824667
NCT01824667已完成3 期

Double-blind, Placebo Controlled, Randomised, Multicentered, of Parallel Design Study to Determine the Effect of B-GOS on GI Discomfort in Healthy Adults

Clasado Limited2 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2013年2月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
400
试验地点
2
主要终点
To determine the effect of B-GOS on GI discomfort

研究概览

简要总结

The aim of the study is to evaluate the effects of a new food supplement which is currently available in the market, called Bimuno® (B-GOS), on gastrointestinal discomfort (e.g. bloating, abdominal pain/cramp and flatulence) in adults who often experience these symptoms but are otherwise healthy.

About 400 volunteers will take part in this study, which will last 6 weeks (to include 4 weeks treatment and 2 weeks follow up period).

Episodes of abdominal pain or discomfort (e.g. bloating, abdominal pain/cramp and flatulence), in the absence of diseases, are commonly associated with food or drug intake or with alterations of bowel habit and vary between individuals in frequency and severity.

Some dietary ingredients are known to reduce these symptoms. We have used B-GOS previously in trials with healthy younger and older adults and we have observed a trend towards reducing abdominal bloating. However, the investigators have not tested B-GOS in healthy adults who often experience these symptoms and this is what we will investigate now.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 18 and 65 years old.
  • Presence of bloated feeling or experiencing abdominal fullness, with or without visible distention, often in the last 12 months.
  • Ability to communicate well with the investigator and to comply with the requirements of the entire study.
  • Volunteer has given written informed consent to participate and is willing to participate in the entire study.

排除标准

  • History or evidence of organic disease of the gastrointestinal tract; such as tumour, irritable bowel syndrome, etc., within the previous 5 years.
  • Undergone surgical resection of any part of the bowel.
  • History of malignancy within the previous 5 years (with exception of well-treated basal cell carcinoma or in situ cervical carcinoma).
  • Received antibiotics in the previous four weeks.
  • Consumed probiotic or prebiotic preparations on a regular basis (at least 3 times per week) in the last 2 weeks.
  • Former participation in another study involving prebiotic or probiotic preparations or investigational drugs within the previous one month, or intention to use such drugs during the course of the study.
  • Severe allergy or any history of severe abnormal drug reaction, drug or alcohol abuse.
  • Regular use of any medication with exception of hormonal replacement therapy and contraception.
  • Women who are pregnant or breast-feeding.
  • Fertile women not practicing a medically-approved method of contraception.

结局指标

主要结局

To determine the effect of B-GOS on GI discomfort

时间窗: Participants will be followed daily for 6 weeks

questionnaires

次要结局

  • To conduct an assessment of stools(Participants will be followed daily for 6 weeks.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验